MarketCap
Facebook
X
TelegramQuarterly report 2023-Q3
added 12-12-2023
Akumin Total Current Liabilities 2011-2026 | AKU
Annual Total Current Liabilities Akumin
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 169 M | 164 M | 52 M | 48.6 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 169 M | 48.6 M | 108 M |
Total Current Liabilities of other stocks in the Diagnostics research industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Accelerate Diagnostics
AXDX
|
66.6 M | - | -61.36 % | $ 2.46 M |  USA |
 |
Burning Rock Biotech Limited
BNR
|
372 M | $ 22.79 | 1.92 % | $ 246 M |  China |
 |
Biocept
BIOC
|
5.51 M | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
39.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
BioNano Genomics
BNGO
|
37.3 M | $ 1.61 | 0.89 % | $ 2.05 M | USA |
 |
Castle Biosciences
CSTL
|
49.4 M | $ 40.16 | -1.12 % | $ 1.12 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
13.8 M | - | - | $ 562 M |  Britain |
 |
Co-Diagnostics
CODX
|
5.75 M | $ 5.76 | -4.48 % | $ 169 M | USA |
 |
DarioHealth Corp.
DRIO
|
12.5 M | $ 12.5 | 3.05 % | $ 355 M |  Israel |
 |
DermTech
DMTK
|
13.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
Fulgent Genetics
FLGT
|
72.9 M | $ 28.01 | - | $ 847 M | USA |
 |
Danaher Corporation
DHR
|
6.8 B | $ 235.87 | 0.12 % | $ 172 B | USA |
 |
Global Cord Blood Corporation
CO
|
647 M | - | - | $ 399 M | China |
 |
DexCom
DXCM
|
1.56 B | $ 68.01 | -2.98 % | $ 26.3 B | USA |
 |
Fluidigm Corporation
FLDM
|
54.2 M | - | 1.08 % | $ 308 M | USA |
 |
Enzo Biochem
ENZ
|
24.8 M | - | -8.98 % | $ 14.8 K | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.27 B | - | - | $ 10.7 B | USA |
 |
Exact Sciences Corporation
EXAS
|
732 M | $ 101.7 | 0.07 % | $ 18.8 B | USA |
 |
CareDx, Inc
CDNA
|
78.1 M | $ 18.13 | -4.07 % | $ 975 M | USA |
 |
Celcuity
CELC
|
31.7 M | $ 108.23 | -0.87 % | $ 4.27 B | USA |
 |
Anixa Biosciences
ANIX
|
2.5 M | $ 3.32 | 1.22 % | $ 106 K | USA |
 |
Guardant Health
GH
|
226 M | $ 109.17 | -0.69 % | $ 13.4 B | USA |
 |
Aspira Women's Health
AWH
|
5.78 M | - | -6.19 % | $ 10.5 M | USA |
 |
Heska Corporation
HSKA
|
39.6 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
8.27 M | - | -20.0 % | $ 1.06 M | USA |
 |
IQVIA Holdings
IQV
|
6.96 B | $ 241.42 | -1.17 % | $ 43.8 B | USA |
 |
Illumina
ILMN
|
1.55 B | $ 146.4 | -2.49 % | $ 23.3 B | USA |
 |
Charles River Laboratories International
CRL
|
994 M | $ 213.74 | -1.62 % | $ 11 B | USA |
 |
Mettler-Toledo International
MTD
|
1.17 B | $ 1 478.71 | 0.58 % | $ 31.4 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
164 M | $ 6.64 | 0.15 % | $ 602 M | USA |
 |
National Research Corporation
NRC
|
36.2 M | $ 19.3 | 2.12 % | $ 474 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
2.17 B | $ 178.17 | -0.02 % | $ 19.8 B | USA |
|
Biodesix
BDSX
|
14.3 M | $ 5.88 | -1.34 % | $ 762 M | USA |
 |
Natera
NTRA
|
310 M | $ 245.0 | -3.7 % | $ 24.1 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
3.33 B | $ 255.84 | 0.86 % | $ 21.5 B | USA |
 |
Motus GI Holdings
MOTS
|
3.27 M | - | -34.28 % | $ 263 K | Israel |
 |
OPKO Health
OPK
|
193 M | $ 1.35 | -0.44 % | $ 937 M | USA |
 |
ICON Public Limited Company
ICLR
|
2.8 B | $ 188.64 | -7.04 % | $ 15.6 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
1.07 B | $ 697.49 | -2.39 % | $ 57.5 B | USA |
 |
Lantheus Holdings
LNTH
|
241 M | $ 69.3 | -0.11 % | $ 4.8 B | USA |
 |
Agilent Technologies
A
|
1.71 B | $ 147.05 | -0.5 % | $ 44.7 B | USA |
 |
Biomerica
BMRA
|
1.74 M | $ 2.7 | -2.87 % | $ 6.2 M | USA |
 |
Bioventus
BVS
|
175 M | $ 7.79 | 2.31 % | $ 488 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1.81 M | - | - | $ 9.42 M | Israel |